Alert detail
LCD L39345: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma — Palmetto GBA
What changed
Palmetto GBA finalizes coverage for melanoma molecular dx assays in 7 states.
Who’s affected: Dermatology billing teams · Effective: August 6, 2023
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.